Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PolyPill for Prevention of Cardiovascular Disease (PolyPars)
NCT03459560Phase 3Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2015
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of enalapril, valsartan, hydrochlorothiazide, atorvastatin, aspirin in cardiovascular disease (CVD), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
enalaprilvalsartanhydrochlorothiazideatorvastatinaspirin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03459560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03459560.